Tech guru who swapped blood with teenage son reveals he scraps 100k a month anti-aging projects

Tech guru who swapped blood with teenage son reveals he scraps 100k a month anti-aging projects

A California biohacking guru who swapped blood with his teenage son as an anti-aging treatment has scrapped the ‘Blood Boy’ project because ‘no benefit was found.’

Brian Johnson, 45, a tech mogul who nearly 10 years ago sold his business Braintree Venmo to PayPal for $800 million, enlisted his 17-year-old son Talmage and 70-year-old father Richard two months ago for the tri-generation bloodline. Treatment swaps to achieve TK

Last week, Mr Johnson tweeted that he, his son and his father were shedding a liter of blood. Talmage’s plasma was fed intravenously to Mr. Johnson, and Mr. Johnson’s plasma was injected into Richard.

However, imaging and biomarker testing showed no gain in the exchange with her son.

‘Young plasma exchange may be beneficial for biologically older populations or certain conditions. The benefit does not stack in my case on top of my existing interventions,’ Mr Johnson said.

‘Alternative approaches to plasma exchange or young plasma fractions hold promise.’

He said Richard’s results from the test, known as Project Blueprint, are still pending.

In return, Johnson’s 17-year-old son Talmage (left) donated his youthful blood to his father (right), who donated plasma to his 70-year-old father, Richard.

Johnson has a team of more than 30 doctors who regularly measure his blood, heart, liver, kidney, brain, blood vessels and sexual health (pictured with father and son).

At 45, Mr. Johnson, a tech mogul who sold his business, is spending an astonishing $2 million a year on the quest for eternal youth.

Mr. Johnson has spent $2 million a year since he was 18 years old biologically. Her eccentric routine includes downing 80 vitamins and minerals a day, 70 pounds of pureed vegetables a month, working out an hour with 25 different exercises.

He also eats a strict 1,977-calorie diet and has taken more than 33,000 pictures of the inside of his intestines.

A team of more than 30 doctors regularly measures his blood, heart, liver, kidney, brain, blood vessels and sexual health. He claims he now has the heart of a 37-year-old, the skin of a 28-year-old and the fitness of an 18-year-old.

‘I don’t have any death plans at the moment,’ he previously told

Mr. Johnson’s quest for eternal youth began after a messy divorce from the mother of his three children. He found himself 60 pounds overweight, depressed and suffering from violent mood swings due to suicidal thoughts.

‘There was this other Brian, who I called ‘Evening Brian’, and he would appear on the dot at 7 p.m. He’d say, “Hey, you had a great day… why don’t you celebrate tonight and have pizza and cookies and tomorrow we’ll work really hard?”‘ Mr. Johnson said.

‘Then I’d wake up fat, didn’t sleep well, depressed.

‘It took me years to overcome the inner demons. I’ve learned how to recognize him and I’ll say, “Thanks Evening Brian, but that’s not going to happen. We know what happens when we eat too much and we don’t feel like it… right.”

Mr. Johnson got the idea from experiments on mice that showed that old mice were revived when mixed with the blood of young mice.

Aged mice show improvements in cognitive function, metabolism and bone structure.

However, it has not been scientifically tested in humans.

In 2019, the Food and Drug Administration (FDA) issued a warning to consumers, stating that plasma infusions of the young provide ‘no proven clinical benefit’ against senile or age-related diseases such as dementia, Parkinson’s disease, multiple sclerosis and heart disease. disease.

‘Treatments using plasma from young donors have not gone through the rigorous testing that the FDA normally requires to confirm a product’s therapeutic benefits and ensure its safety,’ the agency said.

‘Consequently, reported uses of these products should not be assumed to be safe or effective.’

‘We strongly discourage consumers from pursuing this therapy outside of clinical trials under appropriate institutional review board and regulatory oversight.’


Please enter your comment!
Please enter your name here